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Aims This study aimed to assess functional course in elderly patients undergoing transcatheter aortic valve implantation
(TAVI) and to find predictors of functional decline.
Methods
and results
In this prospective cohort, functional course was assessed in patients ≥70 years using basic activities of daily living
(BADL) before and 6 months after TAVI. Baseline EuroSCORE, STS score, and a frailty index (based on assessment of
cognition, mobility, nutrition, instrumental and basic activities of daily living) were evaluated to predict functional
decline (deterioration in BADL) using logistic regression models. Functional decline was observed in 22 (20.8%) of
106 surviving patients. EuroSCORE (OR per 10% increase 1.18, 95% CI: 0.83–1.68, P ¼ 0.35) and STS score (OR
per 5% increase 1.64, 95% CI: 0.87–3.09, P ¼ 0.13) weakly predicted functional decline. In contrast, the frailty
index strongly predicted functional decline in univariable (OR per 1 point increase 1.57, 95% CI: 1.20–2.05,
P ¼ 0.001) and bivariable analyses (OR: 1.56, 95% CI: 1.20–2.04, P ¼ 0.001 controlled for EuroSCORE; OR: 1.53,
95% CI: 1.17–2.02, P ¼ 0.002 controlled for STS score). Overall predictive performance was best for the frailty
index [Nagelkerke’s R2 (NR2) 0.135] and low for the EuroSCORE (NR2 0.015) and STS score (NR2 0.034). In uni-
variable analyses, all components of the frailty index contributed to the prediction of functional decline.
Conclusion Over a 6-month period, functional status worsened only in a minority of patients surviving TAVI. The frailty index, but
not established risk scores, was predictive of functional decline. Refinement of this index might help to identify
patients who potentially benefit from additional geriatric interventions after TAVI.
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Introduction
Transcatheter aortic valve implantation (TAVI) is an alternative to
surgical aortic valve replacement (SAVR) and medical treatment in
selected patients with severe aortic stenosis. Transcatheter aortic
valve implantation is considered less invasive when compared with
SAVR and may therefore be performed in elderly patients at high
risk for surgery with favourable effects on mortality and quality of
life.1–7 However, these outcomes reflect just one part of the clin-
ical outcome in elderly patients. Functional outcomes are similarly
important in elderly patients as the functional status of a patient
will determine whether the patient is able to live independently
or is dependent on the care from another person. The concept
of activities of daily living (ADL) is a relevant instrument to
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measure a person’s independence from another person’s help.8–10
Though ADL represent an important outcome in elderly people,
no previous study reported ADL as outcome in patients undergo-
ing TAVI.
Many established risk scores, such as EuroSCORE or Society of
Thoracic Surgeons (STS) score, insufficiently assess the risk of
elderly co-morbid patients undergoing surgical cardiovascular pro-
cedures.11–23 For the prediction of mortality after TAVI, it has
been previously shown that risk prediction may be improved by
adding geriatric risk scores to the established scores.23 To the
best of the authors’ knowledge, predictors of a poor functional
outcome have not been reported previously. The present study
has two objectives: (i) to investigate ADL as relevant outcome in
elderly patients undergoing TAVI and (ii) to assess established
risk scores as well as baseline functional status as predictors of
functional decline.
Methods
Study population
Consecutive patients ≥70 years with severe symptomatic aortic sten-
osis and referred for evaluation for TAVI to Bern University Hospital,
Switzerland, between 1 September 2009 and 31 March 2011, were eli-
gible for this ongoing prospective cohort study. Aortic stenosis was
considered severe, if the effective orifice area was ,1 cm2 and/or
,0.6 cm2/m2 body surface area. An interdisciplinary team of interven-
tional cardiologists and cardiac surgeons reviewed the individual cases
and formed a consensus on treatment selection (TAVI, SAVR, or
medical treatment). The consensus was based on several parameters
including anatomic characteristics of the aortic root, vascular access
site specifications, peri-operative risk as calculated with the logistic
EuroSCORE and the STS score, underlying co-morbidities, and
general clinical condition. The treatment was either selected during
the in-hospital evaluation phase or in the following 2 weeks after evalu-
ation. The following patients were excluded from the present study: (i)
patients with a treatment other than TAVI (i.e. SAVR or medical treat-
ment); (ii) patients in whom TAVI was performed as emergency pro-
cedure; (iii) patients who lived abroad and were not able to undergo
follow-up evaluation. All other patients were asked for study participa-
tion. If they provided written informed consent, the geriatric baseline
examination was performed. Of the patients who received the geriatric
baseline examination, the following were also excluded: (i) patients
awaiting a TAVI procedure after 31 March 2011; (ii) patients who
died before TAVI; (iii) patients who crossed over to SAVR or
medical treatment after initial allocation to TAVI; and (iv) patients in
whom the time between geriatric baseline examination and TAVI
was .3 months. The final study population consisted of all patients
in whom TAVI and the geriatric baseline examination was performed
during the study period. This study complies with the Declaration of
Helsinki and was approved by the local Ethics Committee.
Baseline data
Cardiological baseline examination
All participating patients received extensive cardiological baseline
examination during an in-hospital evaluation. Patient history was
recorded including symptoms (e.g. NYHA class), cardiovascular risk
factors, medication, prior cardiovascular events, and further co-
morbidities. Physical examination included the measurement of
weight, height, and blood pressure. Left-ventricular ejection fraction
(LVEF), aortic valve orifice area, and transvalvular mean gradient
were measured with transthoracic or transoesophageal echocardiog-
raphy. All patients underwent cardiac catheterization providing infor-
mation about the presence of coronary artery disease, transvalvular
gradient, cardiac output, aortic valve area, and right side filling pres-
sures. Based on the gathered information, STS score and logistic Euro-
SCORE were calculated. For the purpose of this analysis, both scores
were dichotomized at the following cut points: STS score at ≥5%
(higher risk) vs. ,5% (lower risk) and EuroSCORE at ≥20% (higher
risk) vs. ,20% (lower risk).
Geriatric baseline examination
The geriatric baseline examination during the in-hospital evaluation
consisted of the following validated instruments: Mini Mental State
Exam (MMSE) for cognitive function;24 Timed Get Up and Go Test
(TUG) for gait function;25 Mini Nutritional Assessment (MNA) for nu-
tritional status;26 Basic Activities of Daily Living (BADL);9 and Instru-
mental Activities of Daily Living (IADL).10 For the purpose of this
analysis, the instruments were dichotomized at standard cut points
which were defined a priori according to current literature: MMSE
at ,27 points (cognitive impairment) vs. ≥27 points (normal cognitive
function), TUG at ≥20 s (mobility impairment) vs. ,20 s (normal gait
function), and MNA at ,12 points (at risk of malnutrition) vs. ≥12
points (not at risk of malnutrition).24–26 BADL and IADL were consid-
ered abnormal, if there was at least 1 activity with a limitation.9,10
Frailty index
In order to have a quantitative measure of the patient’s general condi-
tion, a frailty index was defined prior to statistical analysis. According
to existing literature, cognition, mobility, and nutritional status are
the most commonly used components of frailty.27,28 The frailty
index of the present study was calculated as summary score from
the following baseline components: 2 points were assigned, if MMSE
was ,21 points; 1 point was assigned for each of the following:
MMSE ≥ 21 and ,27 points, TUG ≥ 20 s, MNA , 12 points,
BADL ≥ 1 limited activity, IADL ≥ 1 limited activity, and a pre-clinical
mobility disability (defined as decreased frequency of walking 200 m
and/or of climbing stairs during the preceding 6 months). Thus, the
frailty index had a range from 0 to 7 points. For the purpose of this
analysis, the frailty index was dichotomized prior to statistical analysis
at ≥3 points (frail) vs. ,3 points (non-frail).
TAVI procedure
TAVI was performed after the cardiological and geriatric baseline
examination, usually within 2 weeks. Either a Medtronic CoreValveTM
(Medtronic Inc., Minneapolis, MN, USA) or an Edwards Sapien XT bio-
prosthesis (Edwards Lifesciences, Irvine, CA, USA) was implanted. The
transcatheter aortic valve was introduced transfemorally whenever
feasible according to measurements based on CT scan.
Follow-up data
Follow-up was performed 6 months after the TAVI procedure. Mortal-
ity and nursing home admissions were assessed and either known from
the in-hospital stay following the TAVI procedure or reported by the
general practitioner. In all surviving patients, BADL and NYHA class
were assessed during an office visit by a specially trained research as-
sistant. Basic activities of daily living consisted of five daily self-care
tasks, including eating and drinking, getting onto toilet, dressing,
caring for personal hygiene, and moving around inside the house.
Patients were scored for independence in each of the five activities
using a three-step scale (patient was able to perform the activity
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independently, had difficulties managing the activity, or needed help
from another person for the activity). In 17 patients who were not
able to undergo the geriatric follow-up examination during an office
visit, specially trained interviewers assessed BADL and NYHA class
by phone. Eleven phone interviews were performed with the patient
and six with a proxy (e.g. close relative).
Outcomes
Functional decline was the main outcome and defined as a decrease of
≥1 point in the ability to perform BADL between baseline and follow-
up.29 Functional decline is particularly important in elderly people
because deterioration in BADL will imperatively lead to dependence
on other persons’ help which often cannot be offset by an expansion
of support at home and therefore often results in nursing home admis-
sion. The present study evaluated two definitions of functional
outcome: (i) functional decline in survivors and (ii) functional decline
or death (i.e. all-cause mortality) among all study participants.
Statistical analysis
First, mortality and functional course during follow-up were analysed.
A change ≥1 point in the ability to perform BADL between baseline
and follow-up was considered clinically relevant using the method of
the minimal important difference ceiled to the next integer.29 Second-
ly, the following baseline predictors of functional outcome were eval-
uated: logistic EuroSCORE, STS score, frailty index, and the six
components of the frailty index. Uni- and bivariable associations
between predictors and the endpoints were assessed by logistic re-
gression providing odds ratios. Predictors were analysed as continuous
measures and dichotomized at standard cut points. Continuous mea-
sures were either analysed as restricted cubic splines (cardiological
risk scores) or as linear measures (cardiological risk scores and
frailty index with its components) and were divided in subintervals
for interpretational purposes. For the cardiological risk scores, no non-
linear relationship was found. The MMSE was divided in subintervals of
three points to obtain odds ratios for a change of three points and it
was analysed reciprocally as a lower MMSE score indicates a more
severe limitation. The TUG was divided in subintervals of 5 s and
values .30 s were set to 30 s. The MNA was divided in subintervals
of two points and it was analysed reciprocally for the same reason
as for the MMSE. The association of risk predictors was assessed
by Wald-statistics. In bivariable models, a global likelihood ratio
x2-statistic was used to assess a common association of two risk
scores and Nagelkerke’s R-squared (NR2) was used to quantify pre-
dictive ability.30 Exact binomial confidence intervals were derived for
proportions. All P-values were two-sided. Two secondary analyses
were performed: (i) NYHA class at 6-month follow-up was compared
in patients with and without functional decline using x2-statistics; (ii)
the frequency of nursing home admissions during 6-month follow-up
was descriptively analysed. Data were analysed using Stata 11.2 (Stata-
Corp LP, College Station, TX, USA).
Results
Baseline data
Between 1 September 2009 and 31 March 2011, 256 patients aged
at least 70 years with severe aortic stenosis were referred for TAVI
evaluation (Figure 1). Of these, 110 patients fulfilled an exclusion
criterion: 99 patients were excluded due to treatment selection
other than TAVI, six patients lived abroad and were not able to
participate in the follow-up, and five patients underwent TAVI as
emergency procedure. Another 13 patients were excluded as
they were awaiting to undergo TAVI after 31 March 2011, or
because they died before TAVI, crossed-over to medical treatment
or the time between geriatric baseline examination and TAVI was
.3 months. Only 14 patients were not included and did not
receive the geriatric baseline examination although they fulfilled
the inclusion criteria (in 10 patients the geriatric baseline examin-
ation was not performed due to logistic problems and four patients
refused the examination). The study population finally consisted of
119 patients undergoing TAVI. In 103 patients (86.6%), TAVI was
introduced transfemorally, in 15 patients (12.6%) transapically,
and in one patient (0.8%) via subclavian artery.
Baseline characteristics of the study population are shown in
Table 1. Mean age was 83.4+ 4.6 years (range: 71.6–93.2 years).
More than half of the study participants (55.5%) were women.
As patients with low risk scores were advised to undergo SAVR,
the mean logistic EuroSCORE was high (25.3+ 14.2%) and co-
morbidities, such as coronary artery disease, were present in the
majority of patients. At baseline, 32.8% of the patients had mild
or severe cognitive impairment and 38.7% had a moderately or se-
verely impaired gait function (Table 1). This high proportion of
patients with functional limitations was also reflected in a high pro-
portion of patients with a limited ability to perform BADL or IADL.
Fifty-nine patients (49.6%) had a frailty index ≥3 and were consid-
ered to be frail.
Follow-up data
Mortality and functional course
No patient was lost to follow-up (Figure 1). During the 6-month
follow-up, 13 patients (10.9%) died. Eight of these 13 patients
died within 30 days after TAVI (early mortality 6.7%). Only two
patients suffered from an additional non-fatal MACCE (stroke in
both patients).
In all 106 surviving patients, 6-month follow-up information
about BADL was complete. Overall, BADL improved or remained
unchanged in 84 patients (79.2%), whereas functional decline was
observed in 22 patients (20.8%). There were relevant individual
variations in BADL between baseline and follow-up. Among surviv-
ing patients, 25 patients (23.6%) had a limitation in BADL at base-
line, 81 (76.4%) were not limited in BADL at baseline. Among the
25 surviving patients with limitations in BADL at baseline, 13
patients (52.0%, 95% CI: 31.3–72.2%) improved in BADL after
TAVI until follow-up, five patients (20.0%, 95% CI: 6.8–40.7%)
remained unchanged, and seven patients (28.0%, 95% CI: 12.1–
49.4%) experienced a functional decline. Among the 81 surviving
patients without limitations in BADL at baseline, 66 patients
(81.5%, 95% CI: 71.3–89.2%) preserved this ability to perform
BADL independently until follow-up, whereas functional decline
was observed in 15 patients (18.5%, 95% CI: 10.8–28.7%). Of
the 13 patients who improved in BADL after TAVI, 11 were inde-
pendent in BADL at follow-up. Together with the 66 patients who
remained independent from baseline to follow-up, a total of 77
of 106 surviving patients (72.6%) had no limitation in BADL at
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follow-up, whereas 29 patients (27.4%) were limited in at least one
BADL at follow-up.
Of the 59 patients who were frail at baseline, 48 patients (81.4%)
survived until 6-month follow-up. Among these survivors, 15
patients (31.3%) experienced a functional decline. Of the 60
patients who were not frail at baseline, 58 patients (96.7%) sur-
vived until 6-month follow-up. Among these survivors, functional
decline was observed in seven patients (12.1%).
Prediction of functional decline among survivors
Functional decline was observed in 22 surviving patients.
Univariable associations of baseline predictors with functional
decline are shown in Table 2 and Figure 2. The frailty index
was strongly associated with a functional decline, whereas Euro-
SCORE or STS score showed weak evidence for an association
with this outcome. All six components of the frailty index contrib-
uted to the strong association of the frailty index with the
outcome.
Table 3 shows the results of bivariable regression models (frailty
index in combination with logistic EuroSCORE or STS score) and
their association with functional decline. The global likelihood-ratio
x2-statistic shows evidence for a common association with the
outcome. However, the combination with EuroSCORE or STS
score revealed only a small increase of predictive ability in terms
of NR2 and therefore did not markedly improve the overall predic-
tion as compared with the frailty index alone.
Prediction of functional decline and mortality
The combined outcome of functional decline or death was
observed in 35 patients (22 patients with functional decline and
13 patients who died). Univariable associations of baseline predic-
tors with functional decline or death are shown in Table 2 and
Figure 2. Geriatric risk scores were superior as compared with
EuroSCORE or STS score for the prediction of functional
decline or death with the frailty index having the highest NR2.
The bivariable associations (Table 3) show that EuroSCORE or
STS score are no independent predictors of the outcomes, if
Figure 1 Flow chart. Patient flow during study. TAVI, transcatheter aortic valve implantation.
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combined with the frailty index. Again, the frailty index alone
explained most of the data variation and the cardiological risk
scores contributed very few to the explained variance.
Secondary analyses
NYHA class
At baseline, NYHA class III or IV was present in 64 (53.8%) of 119
patients. At 6-month follow-up, this proportion decreased to 16
(15.1%) of 106 surviving patients. Five (22.7%) of 22 patients
with functional decline had NYHA class III or IV at 6-month follow-
up which was not significantly higher than the 11 (13.1%) of 84
patients with NYHA class III or IV among patients without func-
tional decline (P ¼ 0.261).
Nursing home admissions
At baseline, 116 patients lived in their own home, two patients in a
retirement home, and only one patient lived in a nursing home. At
6-month follow-up, 95 of the 106 surviving patients (89.6%) still
lived at home, five patients lived in a retirement home, and six
patients in a nursing home. Of the five patients who moved to a
nursing home during follow-up, three had a functional decline
between baseline and follow-up and the remaining two had limita-
tions in BADL already at baseline which persisted until 6-month
follow-up.
Discussion
This prospective longitudinal cohort study documents favourable
functional status in the majority of elderly patients 6 months
after TAVI. Most patients continued to live independently at
home. A minority of the patients experienced functional decline
or death and the question arises which factors contributed to
this outcome. This study provides evidence that functional limita-
tions prior to TAVI are predictors of functional decline after
TAVI with the proposed frailty index being the strongest predictor.
All components of the frailty index contributed to its high associ-
ation with the outcomes. Patients who are frail before TAVI are at
high risk to lose their independence after TAVI. Global risk scores
such as EuroSCORE or STS score that have been established for
the prediction of mortality did not predict functional decline in
the present study.
To our knowledge, the present study is the first study reporting
functional course and predictors of functional decline after TAVI. In
older patients, functional course and the ability to perform BADL
are particularly important. In this study, all patients who were in-
stitutionalized after TAVI had limitations in their ability to perform
BADL. Therefore, the preservation of the ability to perform
BADL after TAVI and predictors of functional decline are of import-
ance.31 A previous analysis of the present study cohort provided evi-
dence that both established risk scores (EuroSCORE and STS score)
as well as the proposed frailty index independently predict mortality
and MACCE after TAVI.23 The present study suggests that the frailty
index independently predicts functional decline of elderly patients
undergoing TAVI, whereas established risk scores showed weak evi-
dence for an association with functional decline.
This study adds to a growing evidence that geriatric measures
of functional status are important outcomes and predictors of
functional outcomes in elderly patients.11–23 One recent study
found a high prevalence of geriatric syndromes in older patients
with acute cardiac diseases and documented a high impact of
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Table 1 Baseline characteristics
Characteristic All study
participants
(n5 119)
Age, mean+ SD, years 83.4+4.6
Female sex, n (%) 66 (55.5)
Body mass index, mean+ SD, kg/m2 26.0+4.7
Cardiovascular risk factors
Hypertension, n (%) 102 (85.7)
Hypercholesterolaemia, n (%) 80 (67.2)
Current smoker, n (%) 5 (4.2)
Diabetes, n (%) 31 (26.1)
Positive family history, n (%) 19 (16.0)
Medical history
CAD, n (%) 78 (65.5)
Previous myocardial infarction, n (%) 15 (12.6)
Previous stroke, n (%) 6 (5.0)
Chronic heart failure, n (%) 43 (36.1)
Symptoms
Dyspnoea NYHA class III or IV, n (%) 64 (53.8)
Angina CCS III or IV, n (%) 29 (24.4)
Previous syncope, n (%) 16 (13.4)
Medication
ACE-I/ARB, n (%) 60 (50.4)
Diuretic, n (%) 80 (67.2)
Beta-blocker, n (%) 62 (52.1)
Echocardiography
LVEF, mean+ SD, % 50.8+14.2
Mean gradient aortic valve, mean+ SD, mmHg 43.1+15.5
Aortic valve area, mean+ SD, cm2 0.6+0.2
Risk scores
Logistic EuroSCORE, mean+ SD, % 25.3+14.2
STS score, mean+ SD, % 6.4+3.5
Frailty index, mean+ SD, points 2.6+1.8
Components of frailty index
Cognitive impairment (MMSE ,27 points), n (%) 39 (32.8)
Mobility impairment (TUG ≥ 20 s), n (%) 46 (38.7)
At risk of malnutrition (MNA, 12 points), n (%) 53 (44.5)
BADL with ≥1 activity with limitation, n (%) 32 (26.9)
IADL with ≥1 activity with limitation, n (%) 72 (60.5)
Pre-clinical mobility disability, n (%) 42 (35.3)
ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor
blocker; BADL, basic activities of daily living; CAD, coronary artery disease; IADL,
instrumental activities of daily living; LVEF, left-ventricular ejection fraction; MMSE,
mini mental state exam; MNA, mini nutritional assessment; STS, Society of
Thoracic Surgeons; TUG, timed get up and go test.
A.W. Schoenenberger et al.688
these syndromes on functional and clinical outcomes.21 Another
recent study in older patients undergoing percutaneous revascular-
ization found a high prevalence of frailty which was associated with
adverse long-term outcomes.22 The question arises why functional
measures are good predictors. These measures identify patients
with diminished physiological reserves in multiple organ systems
and therefore have the potential to differentiate between patients
with the potential to recover and those at risk to deteriorate after
an intervention.
This study has limitations. First, patients undergoing TAVI were
a selection of elderly, high-risk patients with an increased
EuroSCORE. Old patients with low EuroSCORE were in general
allocated to SAVR, whereas elderly patients with excessive risk
were sometimes assigned to medical treatment. Therefore, the
predictive value of the frailty index has to be reconfirmed in
patients with higher or lower risk, in case TAVI will also be per-
formed in these populations in the future. Secondly, the findings
of this study are based on data from a single centre. Therefore,
confirmation in an independent sample is of importance to
improve generalizability of the findings of the present study.
Thirdly, the sample size was small with 119 patients. This
number and the resulting number of endpoints were not sufficient
to evaluate the frailty index in multivariable models involving more
than two predictor variables. However, the number of 22 patients
with functional decline was sufficient to avoid over-fitting in the
applied univariable and bivariable models.32 The finding that
despite limited sample size the frailty index and all its subcompo-
nents were strong predictors further supports the conclusion of
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Table 2 Univariable associations of risk scores (EuroSCORE, STS score and frailty index) and of the frailty index
components for the prediction of functional decline (defined as deterioration in the ability to perform basic activities of
daily living) and of functional decline or death
Predictor Functional decline Functional decline or death
OR (95% CI) P-value NR2 OR (95% CI) P-value NR2
Risk scores
Logistic EuroSCORE
Linear (OR per 10% increase) 1.18 (0.83–1.68) 0.35 0.015 1.33 (0.99–1.80) 0.06 0.050
Dichotomized (≥20 vs. ,20%) 0.79 (0.31–2.02) 0.62 0.004 1.33 (0.59–3.00) 0.49 0.006
STS score
Linear (OR per 5% increase) 1.64 (0.87–3.09) 0.13 0.034 1.95 (1.08–3.52) 0.03 0.068
Dichotomized (≥5 vs. ,5%) 1.14 (0.44–2.95) 0.78 0.001 1.83 (0.80–4.16) 0.15 0.025
Frailty index
Linear (OR per 1 point increase) 1.57 (1.20–2.05) 0.001 0.135 1.74 (1.38–2.20) ,0.001 0.236
Dichotomized (frail vs. non-frail) 3.31 (1.21–9.03) 0.02 0.085 4.46 (1.85–10.75) 0.001 0.142
Components of frailty index
MMSE
Linear (OR per 3 points decrease) 2.41 (1.23–4.71) 0.01 0.086 2.64 (1.55–4.50) ,0.001 0.150
Dichotomized (,27 vs. ≥27 points) 2.50 (0.94–6.65) 0.07 0.048 3.18 (1.38–7.29) 0.01 0.088
TUG
Linear (OR per 5 s increase) 1.48 (1.13–1.94) 0.004 0.091 1.64 (1.26–2.12) ,0.001 0.161
Dichotomized (≥20 vs. ,20 s) 2.50 (0.95–6.56) 0.06 0.050 4.23 (1.83–9.77) 0.001 0.138
MNA
Linear (OR per 2 points decrease) 1.30 (0.96–1.76) 0.09 0.032 1.51 (1.09–2.10) ,0.001 0.085
Dichotomized (,12 vs. ≥12 points) 3.32 (1.24–8.87) 0.02 0.087 4.14 (1.77–9.65) 0.001 0.133
BADL
Linear (OR per 1 point increase) 1.39 (0.86–2.25) 0.18 0.024 1.63 (1.12–2.37) 0.01 0.071
Dichotomized (≥1 limited activity) 1.71 (0.60–4.85) 0.31 0.015 2.44 (1.04–5.76) 0.04 0.049
IADL
Linear (OR per 1 point increase) 1.45 (1.08–1.94) 0.01 0.093 1.46 (1.13–1.89) 0.004 0.109
Dichotomized (≥1 limited activity) 2.10 (0.74–5.92) 0.16 0.031 2.19 (0.91–5.27) 0.08 0.039
Pre-clinical mobility disability
Dichotomized (disability vs. no disability) 3.23 (0.99–10.59) 0.05 0.078 3.69 (1.33–10.24) 0.01 0.108
Each predictor was assessed as linear measure and after dichotomization at standard cut points (except for pre-clinical mobility disability which can be assessed only as
dichotomous measure).
BADL, basic activities of daily living; CI, confidence interval; IADL, instrumental activities of daily living; MMSE, mini mental state exam; MNA, mini nutritional assessment; NR2,
Nagelkerke’s R-squared; OR, odds ratio; STS, Society of Thoracic Surgeons; TUG, timed get up and go test.
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strong associations between frailty and functional outcome.
Fourthly, due to the small sample size, no analyses could be con-
ducted for the prediction of functional improvement in the small
subgroup of patients with functional limitations at baseline and
thus a potential to improve. Fifthly, frailty is a novel concept in ger-
iatrics, and there is not yet a generally accepted operational defin-
ition of frailty in the literature.27,28 In the present study, frailty was
defined as an index based on validated instruments covering key
subdomains related to frailty and disability in old age. The
advantage of this operational definition of frailty is the inclusion
of cognitive function, an aspect not covered in other operational
definitions of frailty.27 However, prior to clinical use, additional re-
search is needed to confirm the validity of this newly proposed
index.
The present study has research implications. First, studies based
on larger sample sizes are needed for the derivation and validation
of risk scores combining geriatric scores with other scores that
have been found to be predictive of outcomes after TAVI. It is
Figure 2 Odds ratios and 95% confidence intervals of univariable associations of dichotomized risk predictors with functional decline
(defined as deterioration of the ability to perform basic activities of daily living) and functional decline or death in forest plots. BADL, basic
activities of daily living; IADL, instrumental activities of daily living; MMSE, mini mental state exam; MNA, mini nutritional assessment; TUG,
timed get up and go test.
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Table 3 Bivariable associations of frailty index and EuroSCORE or STS score for the prediction of functional decline
(defined as deterioration in the ability to perform basic activities of daily living) and of functional decline or death
Predictor Functional decline Functional decline or death
OR (95% CI) P-value NR2 OR (95% CI) P-value NR2
Combination of frailty index and EuroSCORE
Frailty index linear 1.56 (1.20–2.04) 0.001 0.145 1.73 (1.36–2.20) ,0.001 0.262
Logistic EuroSCORE linear 1.16 (0.79–1.71) 0.46 1.28 (0.93–1.76) 0.13
(P-value from global LR x2) 0.006 ,0.001
Frailty index dichotomized 3.41 (1.24–9.33) 0.02 0.091 4.40 (1.82–10.63) 0.001 0.144
Logistic EuroSCORE dichotomized 0.71 (0.27–1.89) 0.50 1.18 (0.50–2.80) 0.70
(P-value from global LR x2) 0.04 0.002
Combination of frailty index and STS score
Frailty index linear 1.53 (1.17–2.02) 0.002 0.146 1.69 (1.32–2.16) ,0.001 0.251
STS score linear 1.36 (0.67–2.73) 0.39 1.45 (0.75–2.80) 0.26
(P-value from global LR x2) 0.006 ,0.001
Frailty index dichotomized 3.34 (1.18–9.43) 0.02 0.085 4.21 (1.72–10.33) 0.002 0.151
STS score dichotomized 0.95 (0.35–2.60) 0.92 1.48 (0.62–3.54) 0.37
(P-value from global LR x2) 0.05 0.001
Each combination was assessed as linear measure and after dichotomization at standard cut points.
CI, confidence interval; NR2, Nagelkerke’s R-squared; OR, odds ratio; STS, Society of Thoracic Surgeons.
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likely that this results in further improvement of risk prediction.
Secondly, larger studies are also needed to optimize the frailty
index and its subcomponents for the risk prediction after TAVI.
The frailty index was developed based on a priori considerations.
It is likely that the frailty index performs even better, if adapted
for TAVI risk prediction.
This study also has clinical implications. Early identification of
patients at increased risk of functional decline is clinically relevant,
because these patients might benefit from interventions designed
to maintain or improve functional status. In addition to the poten-
tial benefit of the frailty index to improve risk prediction, its com-
ponents used in the present study are part of geriatric assessment,
a procedure developed for identification of problems amenable to
targeted peri-operative interventions (e.g. malnutrition). Recent
systematic analyses of randomized controlled studies demonstrate
that geriatric interventions based on the principle of geriatric as-
sessment improve functional prognosis and decrease nursing
home admissions among older patients.33,34
In conclusion, the present study shows that functional status
improved or was preserved in the majority of surviving patients
after TAVI. Though not specifically developed for risk prediction,
a frailty index calculated as summary score from geriatric in-
struments was a strong predictor of functional decline over a
6-month follow-up period. In contrast, established risk scores of
mortality among cardiac patients, such as the EuroSCORE or the
STS score, did not predict functional decline in this study. Given
the relevance of functional status as a key component of quality
of life among older persons, these findings suggest including geriat-
ric measures in the risk assessment prior to TAVI.
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